These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34670515)

  • 1. A prospective cohort study providing insights for markers of adverse pregnancy outcome in older mothers.
    Lean SC; Jones RL; Roberts SA; Heazell AEP
    BMC Pregnancy Childbirth; 2021 Oct; 21(1):706. PubMed ID: 34670515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse pregnancy outcomes and imbalance in angiogenic growth mediators and oxidative stress biomarkers is associated with advanced maternal age births: A prospective cohort study in Ghana.
    Odame Anto E; Owiredu WKBA; Sakyi SA; Turpin CA; Ephraim RKD; Fondjo LA; Obirikorang C; Adua E; Acheampong E
    PLoS One; 2018; 13(7):e0200581. PubMed ID: 30016351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal placental assessment in the prediction of adverse pregnancy outcome after reduced fetal movement.
    Higgins LE; Myers JE; Sibley CP; Johnstone ED; Heazell AEP
    PLoS One; 2018; 13(11):e0206533. PubMed ID: 30395584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between placenta-associated circulating biomarkers and composite adverse delivery outcome of a likely placental cause in healthy post-date pregnancies.
    Bowe S; Mitlid-Mork B; Georgieva A; Gran JM; Redman CWG; Staff AC; Sugulle M
    Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1893-1901. PubMed ID: 34212381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.
    Smith GC; Crossley JA; Aitken DA; Jenkins N; Lyall F; Cameron AD; Connor JM; Dobbie R
    Obstet Gynecol; 2007 Jun; 109(6):1316-24. PubMed ID: 17540803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Falling Insulin Requirements With Maternal Biomarkers and Placental Dysfunction: A Prospective Study of Women With Preexisting Diabetes in Pregnancy.
    Padmanabhan S; Lee VW; Mclean M; Athayde N; Lanzarone V; Khoshnow Q; Peek MJ; Cheung NW
    Diabetes Care; 2017 Oct; 40(10):1323-1330. PubMed ID: 28798085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental protein levels in maternal serum are associated with adverse pregnancy outcomes in nulliparous patients.
    Parry S; Carper BA; Grobman WA; Wapner RJ; Chung JH; Haas DM; Mercer B; Silver RM; Simhan HN; Saade GR; Reddy UM; Parker CB;
    Am J Obstet Gynecol; 2022 Sep; 227(3):497.e1-497.e13. PubMed ID: 35487327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
    Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine assessment of cerebroplacental ratio at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Akolekar R; Ciobanu A; Zingler E; Syngelaki A; Nicolaides KH
    Am J Obstet Gynecol; 2019 Jul; 221(1):65.e1-65.e18. PubMed ID: 30878322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can information regarding the index stillbirth determine risk of adverse outcome in a subsequent pregnancy? Findings from a single-center cohort study.
    Graham N; Stephens L; Johnstone ED; Heazell AEP
    Acta Obstet Gynecol Scand; 2021 Jul; 100(7):1326-1335. PubMed ID: 33382085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the outcome of pregnancies complicated by increased fetal movements and their relation to underlying causes - A prospective cohort study.
    Sharp I; Adeyeye T; Peacock L; Mahdi A; Farrant K; Sharp AN; Greenwood SL; Heazell AEP
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):91-100. PubMed ID: 32683676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of adverse perinatal outcome by serum placental growth factor and soluble fms-like tyrosine kinase-1 in women undergoing induction of labor.
    Fiolna M; Machuca M; Karampitsakos T; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):604-608. PubMed ID: 31444934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of poor perinatal outcome following maternal perception of reduced fetal movements--a prospective cohort study.
    Dutton PJ; Warrander LK; Roberts SA; Bernatavicius G; Byrd LM; Gaze D; Kroll J; Jones RL; Sibley CP; Frøen JF; Heazell AE
    PLoS One; 2012; 7(7):e39784. PubMed ID: 22808059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the optimal growth charts for use in a preterm population: An Australian state-wide retrospective cohort study.
    Pritchard NL; Hiscock RJ; Lockie E; Permezel M; McGauren MFG; Kennedy AL; Green B; Walker SP; Lindquist AC
    PLoS Med; 2019 Oct; 16(10):e1002923. PubMed ID: 31584941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between maternal sleep practices and late stillbirth - findings from a stillbirth case-control study.
    Heazell A; Li M; Budd J; Thompson J; Stacey T; Cronin RS; Martin B; Roberts D; Mitchell EA; McCowan L
    BJOG; 2018 Jan; 125(2):254-262. PubMed ID: 29152887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association and predictive accuracy of high TSH serum levels in first trimester and adverse pregnancy outcomes.
    Schneuer FJ; Nassar N; Tasevski V; Morris JM; Roberts CL
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3115-22. PubMed ID: 22723328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.